Literature DB >> 8775944

Hypoglycemia associated with the use of fluoxetine.

M A Deeg1, E W Lipkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8775944      PMCID： PMC1303427     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  10 in total

1.  Fluoxetine side-effects mimicking hypoglycaemia.

Authors:  J Lear; A C Burden
Journal:  Lancet       Date:  1992-05-23       Impact factor: 79.321

Review 2.  The safety of fluoxetine--an update.

Authors:  G L Cooper
Journal:  Br J Psychiatry Suppl       Date:  1988-09

3.  Hypoglycemic disorders.

Authors:  F J Service
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

4.  Behaviour of glibenclamide on repeated administration to diabetic patients.

Authors:  L Balant; G R Zahnd; F Weber; J Fabre
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

5.  Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.

Authors:  H J Rogers; R G Spector; P J Morrison; I D Bradbrook
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

Review 6.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

7.  Fluoxetine in the treatment of obese type 2 diabetic patients.

Authors:  M O'Kane; P G Wiles; J K Wales
Journal:  Diabet Med       Date:  1994 Jan-Feb       Impact factor: 4.359

Review 8.  The side effect profile and safety of fluoxetine.

Authors:  J F Wernicke
Journal:  J Clin Psychiatry       Date:  1985-03       Impact factor: 4.384

9.  Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals.

Authors:  B J Potter van Loon; J K Radder; M Frölich; H M Krans; A H Zwinderman; A E Meinders
Journal:  Int J Obes Relat Metab Disord       Date:  1992-02

10.  Fluoxetine treatment of the obese diabetic.

Authors:  D S Gray; K Fujioka; W Devine; G A Bray
Journal:  Int J Obes Relat Metab Disord       Date:  1992-03
  10 in total
  11 in total

Review 1.  Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports.

Authors:  Star Khoza; Jamie C Barner
Journal:  Int J Clin Pharm       Date:  2011-04-13

2.  Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells.

Authors:  Joana Almaça; Judith Molina; Danusa Menegaz; Alexey N Pronin; Alejandro Tamayo; Vladlen Slepak; Per-Olof Berggren; Alejandro Caicedo
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

Review 3.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia.

Authors:  Nicole M Sanders; Charles W Wilkinson; Gerald J Taborsky; Salwa Al-Noori; Wendi Daumen; Aryana Zavosh; Dianne P Figlewicz
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-11       Impact factor: 4.310

5.  Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes.

Authors:  Betina Biagetti; Rosa Corcoy
Journal:  World J Clin Cases       Date:  2013-08-16       Impact factor: 1.337

6.  Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes.

Authors:  Julia K Panzer; Alejandro Caicedo
Journal:  Diabetes       Date:  2021-12       Impact factor: 9.461

7.  Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy.

Authors:  Dinesh Giri; Victoria Price; Zoe Yung; Mohammed Didi; Senthil Senniappan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

8.  Effect of Fluoxetine on an Experimental Model of Diabetes-induced Neuropathic Pain Perception in the Rat.

Authors:  S V Tembhurne; D M Sakarkar
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

9.  Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals.

Authors:  Vanessa J Briscoe; Andrew C Ertl; Donna B Tate; Sheila Dawling; Stephen N Davis
Journal:  Diabetes       Date:  2008-06-20       Impact factor: 9.461

10.  Hypoglycemic episodes in a case of Prementrual Dysphoric Disorder on sertraline.

Authors:  Ranjita Santra Dhali; Prithwijit Banerjee; Santanu Munshi; Patralekha Ray Chaudhuri
Journal:  Indian J Pharmacol       Date:  2015 Sep-Oct       Impact factor: 1.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.